Abbott has unveiled preliminary results from a study that is being carried out by the University of Edinburgh researchers on the company’s Architect Stat High Sensitive Troponin-I (hsTnI) test, at ESC (European Society of Cardiology) ...
January was a month of change for healthcare giant Abbott said a senior medical devices analyst from GlobalData who asserted that the company’s latest cardiac diagnostics product represents a pathway to growth over the next few years. ...
Tags: Abbott, Diagnostics, medical devices analyst
Abbott has obtained CE mark approval for its Architect Stat high sensitive Troponin-I assay, designed for evaluating potential heart attacks sooner. The chemiluminescent microparticle immunoassay (CMIA), which is designed for use on ...
Tags: Abbott, CE mark, Architect Stat, potential heart attacks